Financhill
Back

Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings

Rhythm Pharmaceuticals Price Quote

$39.35

Rhythm Pharmaceuticals Key Stats

Buy
58
Rhythm Pharmaceuticals (RYTM) is a Buy

Day range:
$37.49 - $41.76
52-week range:
$15.50 - $52.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.31
P/B ratio:
14.13%

Volume:
1.2M
Avg. volume:
571.3K
1-year change:
135.77%
Market cap:
$2.4B
Revenue:
$77.4M
EPS:
$-3.2

How Much Does Rhythm Pharmaceuticals Make?

Is Rhythm Pharmaceuticals Growing As A Company?

Rhythm Pharmaceuticals Stock Price Performance

What Is Rhythm Pharmaceuticals 52-Week High & Low?

Rhythm Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rhythm Pharmaceuticals?

Is Rhythm Pharmaceuticals Cash Flow Positive?

  • What Is RYTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$136.2M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $74.4M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.7M

Rhythm Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RYTM return on invested capital is -89.34%
  • What Is Rhythm Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -53.53%
  • What Is RYTM Return On Equity?
    ROE is a measure of profitability and is -89.34%

Rhythm Pharmaceuticals Earnings Date & Stock Price

Rhythm Pharmaceuticals Competitors

Rhythm Pharmaceuticals Dividend Yield

Data Unavailable

Rhythm Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.22%
Revenue: 175.7% -3.46%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 56.89
Upside from Last Price: 44.57%

Major Shareholders

  • How many RYTM shares are owned by institutional investors?
    102.7M RYTM shares are owned by institutional investors
  • How many RYTM shares are owned by insiders?
    1.1M RYTM shares are owned by insiders